There are 2789 resources available
806P - Genomic alteration characteristics and potential drug targets of uterine sarcoma
Presenter: Fengxia Xue
Session: ePoster Display
807P - Multi-centre study of escalated etoposide/cisplatin (Esc-EP) as a novel salvage regimen in advanced/refractory gestational trophoblastic neoplasia
Presenter: James Clark
Session: ePoster Display
808P - Characteristics and outcomes of women with adenocarcinoma versus squamous cell carcinoma of the vulva: A Japanese Gynecologic Oncology Group study
Presenter: Shin Nishio
Session: ePoster Display
874P - Concurrent chemoradiation with cisplatin alone versus cisplatin and capecitabine in treatment of locally advanced head and neck cancer
Presenter: Abhishek Krishna
Session: ePoster Display
Resources:
Abstract
810P - Hormonal receptors in uterine leiomyosarcomas: How far is a primary tumor from multiple metastases?
Presenter: Élia Cipriano
Session: ePoster Display
921P - Assessment of health-related quality of life in head and neck cancer patients treated with chemoradiation
Presenter: VINAYAKUMAR MUTTAGI
Session: ePoster Display
922P - Efficacy of immunotherapy (IO) and subsequent systemic treatment after failure of IO in patients with recurrent or metastatic head and neck cancer in a real-world setting
Presenter: Michael Pogorzelski
Session: ePoster Display
923P - Nivolumab in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck (R/M SCCHN) progressing on/or after a platinum-based therapy: Interim analysis of a prospective French real-world study (ProNiHN)
Presenter: Christophe Le Tourneau
Session: ePoster Display
924P - HANNA: Effectiveness and quality-of-life data from a real-world study of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab in Germany
Presenter: Harald Müller-Huesmann
Session: ePoster Display
872P - Association between event-free (EFS) and overall survival (OS) in newly diagnosed patients (pts) with locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) ineligible for surgery
Presenter: Christopher Black
Session: ePoster Display